Clinical Trial

Retrospective Analyses of TrakStar Database

Recruiting
View on ClinicalTrials.gov →
Summary
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-31.
Trial Details
NCT Number NCT06917339
Lead Sponsor Neuronetics
Conditions Depression, Obsessive-Compulsive Disorder, Anxiety Depression
Enrollment 156,000 participants
Start Date 2025-02-25
Primary Completion 2035-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-09